Dosage for coadministering drug and percutaneous absorption enha

Surgery – Controlled release therapeutic device or system – Osmotic or diffusion pumped device or system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

128156, A61M 700

Patent

active

043794548

ABSTRACT:
A dosage form that coadministers a drug and a percutaneous absorption enhancer to a defined area of the skin. The dosage form comprises a body that contains supplies of drug and enhancer and has a basal surface that contacts the area of skin and transmits the drug and enhancer to the area for absorption thereby. The drug is provided to the basal surface at a rate at least as great as the rate at which the skin is able to absorb the drug whereas the enhancer is via a rate controlling means at a substantially constant rate that increases the permeability of the treated area of skin to the drug to a level at which the drug is absorbed at a therapeutically effective rate.

REFERENCES:
patent: 3731683 (1973-05-01), Zaffaroni
patent: 4060084 (1977-11-01), Chandrasekaran
patent: 4096239 (1978-06-01), Katz et al.
patent: 4230105 (1980-10-01), Harwood
patent: 4286592 (1981-09-01), Chandrasekaran
patent: 4291014 (1981-09-01), Keith et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dosage for coadministering drug and percutaneous absorption enha does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dosage for coadministering drug and percutaneous absorption enha, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage for coadministering drug and percutaneous absorption enha will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-936090

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.